Ophthalmology · Elmhurst, IL
NPI
1881613297
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
152 N Addison Ave
Elmhurst, IL, 60126
Phone (630) 833-9621
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
32,210 services
Medicare patients, 2024
521
Average age 76
Drug cost, 2024
$337K
2,767 prescriptions
Company payments, 2025
$12K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saad Ahmad was code J2781 (injection, pegcetacoplan, intravitreal, 1 mg), 10,470 times for 77 patients. In total Saad Ahmad billed 32,210 services in 62 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2781 Injection, pegcetacoplan, intravitreal, 1 mg | Office | 10,470 | 77 | $117.04 | $1.2M |
| J2777 Injection, faricimab-svoa, 0.1 mg | Office | 9,480 | 100 | $27.89 | $264K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 2,728 | 131 | $263.64 | $719K |
| 99214 Office E&M - Established | Office | 2,506 | 448 | $98.72 | $247K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,955 | 493 | $31.02 | $61K |
| 67028 Intravitreal Injection | Office | 1,748 | 249 | $87.98 | $154K |
| 92250 Angiography | Office | 1,033 | 392 | $29.22 | $30K |
| 92235 Angiography | Office | 658 | 358 | $128.33 | $84K |
| J9035 Injection, bevacizumab, 10 mg | Office | 272 | 114 | $55.73 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 220 | 159 | $13.06 | $2,873 |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 140 | 14 | $161.19 | $23K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 140 | 36 | $0.75 | $105 |
| 92014 Ophthalmological E&M | Office | 104 | 66 | $91.23 | $9,488 |
| J3490 Unclassified drugs | Office | 73 | 47 | $2,113.93 | $154K |
| 67516 Eye | Office | 62 | 34 | $97.57 | $6,050 |
By year: 2022 $2.8M for 24,713 services; 2023 $3.3M for 61,511 services; 2024 $3.2M for 32,210 services.
Medicare prescription drug claims, 2024
In 2024, the drug Saad Ahmad prescribed most often to Medicare patients was Difluprednate, with 818 prescriptions and refills. In total Saad Ahmad wrote 2,767 Medicare prescriptions that cost $337K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Difluprednate Generic | 818 | 843 | 222 | $95K |
| Dorzolamide Hcl Generic | 489 | 722 | 163 | $8,435 |
| Bromfenac Sodium Generic | 288 | 297 | 65 | $69K |
| Brinzolamide Generic | 281 | 363 | 101 | $45K |
| Prolensa Bromfenac Sodium | 145 | 148 | 35 | $53K |
| Gentamicin Sulfate Generic | 145 | 145 | 125 | $998 |
| Prednisolone Acetate Generic | 124 | 150 | 49 | $4,005 |
| Simbrinza Brinzolamide/Brimonidine Tart | 71 | 112 | 21 | $14K |
| Latanoprost Generic | 69 | 143 | 28 | $550 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 56 | 68 | 18 | $5,365 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 46 | 84 | 19 | $634 |
| Atropine Sulfate Generic | 37 | 42 | 20 | $783 |
| Combigan Brimonidine Tartrate/Timolol | 32 | 43 | 13 | $7,733 |
| Ketorolac Tromethamine Generic | 31 | 43 | Under 11 | $934 |
| Brimonidine Tartrate Generic | 20 | 29 | Under 11 | $110 |
Brand drugs: 764 claims; generic drugs: 2,003 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saad Ahmad $12K ($12K in general payments such as food, travel and fees) from 13 companies. The largest payer was Genentech USA, Inc. with $6,620.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 43 | $6,620 |
| Astellas Pharma US Inc 4503.T | 15 | $2,250 |
| ANI Pharmaceuticals, Inc. ANIP | 25 | $1,889 |
| Apellis Pharmaceuticals, Inc. APLS | 27 | $623 |
| Abbvie Inc. ABBV | 15 | $236 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $212 |
| Harrow Eye, LLC | 6 | $183 |
| LKC Technologies, Inc. | 3 | $106 |
| Mallinckrodt Hospital Products Inc. | 4 | $103 |
| Alcon Vision LLC ALC | 4 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.